Paradigm Therapeutics is Drug Discovery in United Kingdom that focus on late stage business. Founded in 1999. They cover business area such as developer, drug, model genetic, bioinformatic, target identification and validation service, technology, vivo pharmacology, late stage pre-clinical project, pain, CNS disorder, hormone dependent disease, prostate, breast, cancer, metabolic disease, diabetes, hyperlipidemias, obesity, osteoporosis.
1999
( 25 years old in 2024 )
Late Stage
-
214 Cambridge Science Park
Cambridge CB4 0WA
England, United Kingdom
Private
developerdrugmodel geneticbioinformatictarget identification and validation servicetechnologyvivo pharmacologylate stage pre-clinical projectpainCNS disorderhormone dependent diseaseprostatebreastcancermetabolic diseasediabeteshyperlipidemiasobesityosteoporosis
* We use standard office opening hours in near Paradigm Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Paradigm Therapeutics is Drug Discovery business from United Kingdom that founded in 1999 (25 years old in 2024), Paradigm Therapeutics business is focusing on Late Stage.
Paradigm Therapeutics headquarter office and corporate office address is located in 214 Cambridge Science Park Cambridge CB4 0WA England, United Kingdom.
Paradigm Therapeutics was founded in United Kingdom.
In 2024, Paradigm Therapeutics is currently focus on late stage sector.
Above is snippet of Google Trends for "late stage" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Paradigm Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
